期刊文献+

齐墩果酸纳米悬浮液的制备 被引量:10

Preparation of Oleanolic Acid Nanosuspension
下载PDF
导出
摘要 目的探讨运用高压匀质技术制备齐墩果酸纳米悬浮液的可行性。方法以纳米粒粒径及多分散指数为指标,研究各影响因素如压力、循环次数、表面活性剂种类及用量对纳米悬浮液的影响。并研究纳米化齐墩果酸的溶解度及体外溶出行为。结果匀质压力是决定纳米粒粒径的最主要因素,增加循环次数可以使纳米粒的单分散性增加,表面活性剂对维持体系稳定性起着不可忽视的作用。纳米化齐墩果酸的溶解度及药物溶出速率得到明显提高。结论高压匀质技术可以成功用于制备齐墩果酸纳米悬浮液。 OBJECTIVE To study the preparation of oleanolic acid nanosuspension by means of high-pressure homogenization technique. METHODS Oleanolic acid nanosuspension was prepared with different pressure, homogenization cycles, and surfactants, Average particle size and the polydispensible index (PI) were measured to investigate the influences of these operation parameters on the nanosuspensions. The solubility and dissolution of drug nanoparticles were also investigated, RESULTS Homogenization pressure was the major factor that determined the average particle size, increased homogenization cycles led to a decreased PI, and suffactants helped to keep the system stable. Compared to crude drug powder, the solubility and dissolution of drug nanoparticles were evidently improved. CONCLUSION High-pressure homogenization technique can be used successfully to prepare oleanolic acid nanosuspensions.
出处 《中国药学杂志》 CAS CSCD 北大核心 2006年第12期924-927,共4页 Chinese Pharmaceutical Journal
关键词 齐墩果酸 纳米悬浮液 高压匀质 oleanolic acid nanosuspension high-pressure homogenization
  • 相关文献

参考文献9

  • 1LIU J.Pharmacology of oleanolic acid and ursolic acid[J].J Ethnopharmacol,1995,49:57-68. 被引量:1
  • 2WANG B JIANG C H.Studies on oleanolic acid[J].Chin Pharm J 中国药学杂志,1992,27(73):393-395. 被引量:1
  • 3WANG D R.Progresses in the research of oleanolic acid[J].天津药学,2003,15(3):56-58. 被引量:1
  • 4江波,印春华.提高难溶性药物口服生物利用度的方法[J].中国医药工业杂志,2002,33(7):358-362. 被引量:41
  • 5柯学平,其能,朱颖.使用微粉化技术改善头孢呋新酯片的溶出[J].中国药科大学学报,2000,31(3):188-191. 被引量:7
  • 6LIVERSIDGE G G,CUNDY K C.Particle size reduction for improvement of oral bioavailability of hydrophobic drugs:Absolute oral bioavailability of nanocrystalline danazol in beagle dogs[J].Int J Pharma,1995,125:91-97. 被引量:1
  • 7M(U)LLER R H,JACOBS C,KAYSER O.Nanosuspensions as particulate drug delivery formulations in therapy.Rationale for development and what we can expect for the future[J].Adv Drug Delivery Review,2001,47:3-19. 被引量:1
  • 8LIVERSIDGE E M,LIVERSIDGE G G,COOPER E R.Nanosizing:a formulation approach for poorly-water-soluble compounds[J].Eur J Pharm Sci,2003,18:113-120. 被引量:1
  • 9M(U)LLER R H,PETERS K.Nanosuspensions for the poorly soluble drugs Ⅰ Preparation by a size reduction technique[J].Int J Pharm,1998,160:229-237 被引量:1

二级参考文献6

共引文献46

同被引文献144

引证文献10

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部